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Pattern Discovery in Brain Imaging
Genetics via SCCA Modeling with a
Generic Non-convex Penalty
Lei Du1, Kefei Liu2, Xiaohui Yao 2, Jingwen Yan2, Shannon L. Risacher2, Junwei Han1, Lei
Guo1, Andrew J. Saykin 2, Li Shen 2 & the Alzheimer’s Disease Neuroimaging Initiative*
Brain imaging genetics intends to uncover associations between genetic markers and neuroimaging
quantitative traits. Sparse canonical correlation analysis (SCCA) can discover bi-multivariate
associations and select relevant features, and is becoming popular in imaging genetic studies. The L1norm function is not only convex, but also singular at the origin, which is a necessary condition for
sparsity. Thus most SCCA methods impose 1-norm onto the individual feature or the structure level of
features to pursuit corresponding sparsity. However, the 1-norm penalty over-penalizes large
coefficients and may incurs estimation bias. A number of non-convex penalties are proposed to reduce
the estimation bias in regression tasks. But using them in SCCA remains largely unexplored. In this
paper, we design a unified non-convex SCCA model, based on seven non-convex functions, for unbiased
estimation and stable feature selection simultaneously. We also propose an efficient optimization
algorithm. The proposed method obtains both higher correlation coefficients and better canonical
loading patterns. Specifically, these SCCA methods with non-convex penalties discover a strong
association between the APOE e4 rs429358 SNP and the hippocampus region of the brain. They both
are Alzheimer’s disease related biomarkers, indicating the potential and power of the non-convex
methods in brain imaging genetics.
By identifying the associations between genetic factors and brain imaging measurements, brain imaging genetics
intends to model and understand how genetic factors influence the structure or function of human brain1–14. Both
genetic biomarkers such as single nucleotide polymorphisms (SNPs), and brain imaging measurements such as
imaging quantitative traits (QTs) are multivariate. To address this problem, bi-multivariate association models,
such as multiple linear regression15, reduced rank regression16–18, parallel independent component analysis19,
partial least squares regression20,21, canonical correlation analysis (CCA)22 and their sparsity-inducing variants23,
have been widely used to uncover the joint effect of multiple SNPs on one or multiple QTs. Among them, SCCA
(Sparse CCA), which can discover bi-multivariate relationships and extract relevant features, is becoming popular
in brain imaging genetics.
The CCA technique has been introduced for several decades24. CCA can only perform well when the number
of observations is larger than the combined feature number of the two views. Unfortunately, the problem usually
is a large-p-small-n problem in the biomedical and biology studies. And it gets even worse because in CCA we are
facing a large-(p + q)-small-n problem. In order to overcome this limitation, sparse CCA (SCCA)25–36 employs a
sparsity inducing regularization term to select a small set of relevant features and has received increasing attention. The 1-norm based SCCA method25 has gained great success for its sparsity pursuing capability. After that,
there are many SCCA variants based on the 1-norm. For examples, the fused lasso penalty imposes the 1-norm
onto the ordered pairwise features25, and the group lasso penalty imposes the 1-norm onto the group of features29,32. Further, the graph lasso or the graph guided lasso can be viewed as imposing the 1-norm onto the
pairwise features defined by an undirected graph29.
However, the 1-norm penalty shows the conflict of optimal prediction and consistent feature selection37. In
penalized least squares modeling, Fan and Li38 showed that a good penalty function should meet three properties.
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First, the penalty function should be singular at the origin to produce sparse results. Second, it should produce
continuous models for stable model selection, and third, the penalty function should not penalize large coefficients to avoid estimation bias. The 1-norm penalty is successful in feature selection because it is singular at the
origin. On the contrary, the 1-norm penalty over-penalizes large coefficients, and thus it may be suboptimal with
respect to the estimation risk39,40. The 0-norm function which only involves the number of nonzero features is an
ideal sparsity-inducing penalty. However, it is neither convex nor continuous, and thus solving 0-norm constrained problem is NP-hard41.
A number of non-convex penalties are proposed as the surrogate of the 0-norm to handle this issue. These
penalties includes the  γ -norm (0 < γ < 1) penalty42, the Geman penalty43, the Smoothly Clipped Absolute
Deviation (SCAD) penalty38, the Laplace penalty44, the Minimax Concave Penalty (MCP)45, the Exponential-Type
Penalty (ETP)46 and the Logarithm penalty47. These non-convex functions have attractive theoretical properties
for they all are singular at the origin and leave those larger coefficients unpenalized. Though they have gained
great success in generalized linear models (GLMs), it is an unexplored topic to apply them to the SCCA models
for achieving sparsity and unbiased prediction simultaneously.
Therefore, it is essential and of great interest to investigate performances of various SCCA models based on
these non-convex penalties. A major challenge of non-convex function is the computational complexity. The local
quadratic approximation (LQA) technique is introduced to solve the SCAD penalizing problem38. LQA approximates the objective by a locally quadratic expression which can be solved like a ridge constrained problem.
Inspired by this, in this paper, we propose a generic non-convex SCCA models with these non-convex penalties,
and propose a unified optimization algorithm based on the LQA technique and the Alternate Convex Search
(ACS) method48. Using both synthetic data and real imaging genetic data, the experimental results show that with
appropriate parameters, the non-convex SCCA methods have better performance on both canonical loading
patterns and correlation coefficients estimation than the 1-norm based SCCA methods.

Methods

Throughout this paper, scalars are denoted as italic letters, column vectors as boldface lowercase letters, and
matrices as boldface capitals. The u denotes the Euclidean norm of a vector u.
Sparse Canonical Correlation Analysis (SCCA). Let X ∈ n ×p be a matrix representing the
SNP biomarkers data, where n is the number of participants and p is the number of SNPs. Let Y ∈ n ×q be the
QT data with q being the number of imaging measurements. A typical SCCA model is defined as

Preliminaries.

min − uΤXΤYv

(1)

u, v

s.t.

Xu

2

2

≤ 1, Yv

≤ 1, Ω(u) ≤ c1, Ω(v) ≤ c 2,

where Xu and Yv are the canonical variables, u and v are the corresponding canonical vectors we desire to estimate, and c1, c2 are the tuning parameters that control the sparsity level of the solution. The penalty function could
be the 1-norm penalty, or its variants such as the fused lasso, group lasso and graph lasso25,27,29,32,34.
Non-convex Penalty Functions for SCCA. In this paper, we investigate seven non-convex surrogate penalties of
0-norm in the SCCA model. They are singular at the origin, which is essential to achieve sparsity in the solution.
And they do not overly penalize large coefficients. In order to facilitate a unified description, we denote the
non-convex penalty as
Ωnc(u) =

p

∑Pλ ,γ(|ui|),

(2)

i=1

where λ and γ are nonnegative parameters, and Pλ,γ(|ui|) is a non-convex function. We absorb λ into the penalty
because it cannot be decoupled from several penalties, such as the SCAD function38. We here have seven penalties
and they are described in Table 1 and visualized in Fig. 1, where for clarity we have dropped the subscript i in ui.
There is a sharp point at the origin for each of them, indicating that they are singular at the origin. This is essential
to achieve sparseness in the solution. Besides, these curves are concave in |ui| and monotonically decreasing on
(−∞, 0], and monotonically increasing on [0, ∞). Therefore, though these penalties are not convex, they are
piecewise continuously differentiable and their supergradients exist on both (−∞, 0] and [0, ∞)49. Table 1 also
shows their supergradients P′λ,γ(|ui|) with respect to |ui|.

The Proposed Non-convex SCCA Model and Optimization Algorithm. Replacing the 1-norm constraints in the SCCA model, we define the unified non-convex SCCA model as follows
min − uΤXΤYv + Ωnc(u) + Ωnc(v)
u, v

s.t.

Xu

2

≤ 1, Yv

2

(3)

≤ 1,

where Ωnc(u) and Ωnc(v) can be any of the non-convex functions listed in Table 1.
To solve the non-convex SCCA problem, we use the Lagrangian method,
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Penalty Name

Function (Pλ,γ(|u|))

Supergradient (P′λ,γ(|u|))

 γ -norm42

λ|u|γ

∞,
u = 0,



γ− 1


λγ|u| , |u| > 0.

Geman43

λ u
u +γ

SCAD38

Laplace44

MCP45

λγ
2
( u + γ)

λ|u| ,
| u| ≤ λ

− | u |2 +2γλ | u | −λ2

λ ≤ |u| ≤ γλ
,
2(γ − 1)

2
 λ (γ + 1) ,
|u| ≥ γλ.
 2

(

( ))

λ 1 − exp −


λ|u| −

 1 2
 2 γλ ,

|u|2
,
2γ

u
γ

λ
exp
γ

λ
(1
1 − exp(−γ)

Logarithm47

λ
log(γ + 1)

(− )



λ−






 0,

|u| ≤ γλ
|u| ≥ γλ.

ETP46

λ ,

| u| ≤ λ



γλ− | u|

,
λ ≤ |u| ≤ γλ
 γ−1



|u| ≥ γλ.
 0,



u
γ

|u|
,
γ

|u| ≤ γλ
|u| ≥ γλ.

λγ
exp(− γ
1 − exp(−γ)

− exp(− γ u ))

u)

λγ
(γ u + 1)log(γ + 1)

log(γ u + 1)

Table 1. The seven non-convex penalty functions and their supergradients.

(u, v) = − uΤXΤYv + Ωnc(u) + Ωnc(v) +

α1
( Xu
2

2

− 1) +

α2
( Yv
2

2

− 1),

(4)

which is equivalent to
(u, v) = − uΤXΤYv + Ωnc(u) + Ωnc(v) +

α1
Xu
2

2

+

α2
Yv
2

2

(5)

from the point of view of optimization. α1, α2, λ1, λ2 and γ are nonnegative tuning parameters. Next we will show
how to solve this non-convex problem.
The first term −uΤXΤYv on the right of equation (5) is biconvex in u and v. Xu 2 is convex in u, and Yv 2 is
convex in v. It remains to approximate both Ωnc(u) and Ωnc(v) and transform them into convex ones.
The local quadratic approximation (LQA) technique was introduced to quadratically expresses the SCAD
penalty38. Based on LQA, we here show how to represent these non-convex penalties in a unified way. First, we
have the first-order Taylor expansion of Pλ 1, γ( μ ) at μ0 Pλ,γ((μ)1/2) at μ0
Pλ , γ( μ ) ≈ Pλ , γ( μ0 ) + P′λ , γ ( μ0 )

1
(μ − μ0),
2 μ0

(6)

where μ0 and μ are neighbors, e.g., the estimates at two successive iterations during optimization. Substituting
2
μ = ui2 and μ0 = (uit ) into (6), we have
Pλ , γ(|ui |) ≈ Pλ , γ(|uit |) + P′λ , γ (|uit |)

1
(ui2 − (uit )2 )
2|uit |

(7)

with P′λ , γ (|uit |) being the supergradient of Pλ , γ(|uit |) (as shown in Table 1) at |uit |.
Then we obtain a quadratic approximation to Ωnc(u):
Ωnc(u) =

Scientific Reports | 7: 14052 | DOI:10.1038/s41598-017-13930-y
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p

∑Pλ ,γ(|ui|) ≈ ∑
i =1

i =1

P′λ , γ (|uit |)
2|uit |

ui2 + Cu,

(8)
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Figure 1. Illustration of the 0, 1 and seven non-convex functions. All the non-convex penalty functions share
two common properties: They are singular at origin, concave and monotonically decreasing on (−∞,0], and
concave and monotonically increasing on [0,∞).

where
Cu =

p



∑Pλ ,γ(|uit|) −
i =1

1

P′λ , γ (|uit |)|uit |

2

is not a function of u and thus will not contribute to the optimization.
In a similar way, we can construct a quadratic approximation to Ωnc(v)
Ωnc(v) =

q

q

j =1

j =1

∑Pλ ,γ(|vj|) ≈ ∑

P′λ , γ (|v jt|)
2|v jt |

v j2 + C v ,

(9)

where
Cv =

q



∑Pλ ,γ(|vjt|) −
j =1

1

P′λ , γ (|v jt|)|v jt|

2

is not a function of v and makes no contribute towards the optimization.
Denote the estimates of u and v in the t-th iteration as ut and vt, respectively. To update the estimates of u and
v in the (t + 1)-th iteration, we substitute the approximate functions of Ωnc(u) and Ωnc(v) in equations (8) and (9)
into (u, v) in 5, and solve the resultant approximate version of the original problem:

q

+∑

j =1

P′λ 1, γ (|v jt|)
2|v jt|

v j2 +

P′λ 1, γ (|uit |)

p

arg min (u, v) = arg min − uΤXΤYv +

∑

2|uit |

i =1

ui2

α1
α
||Xu ||2 + 2 ||Yv ||2
2
2

(10)

Obviously, the equation (10) is a quadratical expression, and is biconvex in u and v. This means it is convex in
terms of u given v, and vice versa. Then according to the alternate convex search (ACS) method which is designed
to solve biconvex problems48, the (t + 1)-th estimation of u and v can be calculated via
ut +1 = arg min − uΤXΤYv t +
u

p

∑
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2|uit |

i =1

v t +1 = arg min − (ut +1)Τ XΤYv +
v

P′λ 1, γ (|uit |)
q

∑

j =1

ui2 +

P′λ 2 , γ (|v jt|)
2|v jt|

α1
||Xu ||2 ,
2

v j2 +

α2
||Yv ||2 .
2

(11)
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Figure 2. Canonical loadings estimated on four synthetic data sets. The first column shows results for Data1,
and the second column is for Data2, and so forth. The first row is the ground truth, and each remaining one
corresponds to an SCCA method: (1) Ground Truth. (2) L1-SCCA. (3) L1-NSCCA. (4) L1-S2CCA. (5)  γ -norm
and so forth. For each data set and each method, the estimated weights of u is shown on the left panel, and v is
on the right. In each individual heat map, the x-axis indicates the indices of elements in u or v; the y-axis
indicates the indices of the cross-validation folds.

Num

HC

MCI

AD

204

363

176

Gender(M/F)

111/93

235/128

95/81

Handedness(R/L)

190/14

329/34

166/10

Age(mean ± std)

76.07 ± 4.99

74.88 ± 7.37

75.60 ± 7.50

Education(mean ± std)

16.15 ± 2.73

15.72 ± 2.30

14.84 ± 3.12

Table 2. Participant characteristics.

Both equations above are quadratic, and thus their closed-form solutions exist. Taking the partial derivative of
(u, v) in (5) with respect to u and v and setting the results to zero, we have
0 ∈ − XΤYv + (D1t + α1XΤX)u,

(12)

0 ∈ − YΤXu + (Dt2 + α 2 YΤY)v,

(13)

where D1t is a diagonal matrix with the i-th diagonal entry as

P ′λ1, γ (| uit |)
|uit |

(i∈[1, p]). It can be calculated by taking

the partial derivative of equation (7) with respect to ui. Dt2 is also a diagonal matrix with the j-th diagonal entry as
P ′λ1, γ (|v tj |)
(j∈[1, q]), and can be computed similarly. However, the i-th element of D1t does not exist if uit = 0.
t
|v j|

According to perturbed version of LQA50, we address this by adding a slightly perturbed term. Then the i-th element of D1t is
D1t (i, i) =

P′λ 1, γ (|ui |)
|ui | + ζ

(14)

where ζ is a tiny positive number. Hunter and Li showed that this modification guarantees optimizing the equation (11). Then we have the updating expressions at the (t + 1)-th iteration
50
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ut +1 = (D1t + α1XΤX)−1XΤYv t ,

(15)

v t +1 = (Dt2 + α 2 YΤY)−1YΤXut +1.

(16)
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Range of γ

 γ -norm

SCAD

Geman,
Laplace, MCP

ETP, Log

0.1, 0.2, 0.3

3.7

0.1, 0.01, 0.001

10, 100, 1000

Table 3. The searching range of optimal γ for each non-convex penalty.

We alternate between the above two equations to graduate refine the estimates for u and v until convergence.
The pseudo code of the non-convex SCCA algorithm is described in Algorithm 1.

Computational Analysis. In Algorithm 1, Step 3 and Step 6 are linear in the dimension of u and v, and are
easy to compute. Step 4 and Step 7 are the critical steps of proposed algorithm. Since we have closed-form updating expressions, they can be calculated via solving a system of linear equations with quadratic complexity which
avoids computing the matrix inverse with cubic complexity. Step 5 and 8 are the re-scale step and very easy to
calculate. Therefore, the whole algorithm is efficient.
Data Availability.

The synthetic data sets generated in this work are available from the corresponding
authors’ web sites, http://www.escience.cn/people/dulei/code.html and http://www.iu.edu/ shenlab/tools/ncscca/.
The real data set is publicly available in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database repository, http://adni.loni.usc.edu.

Experiments and Datasets

Data Description. Synthetic Dataset. There are four data sets with sparse true signals for both u and v, i.e.,
only a small subset of features are nonzero. The number of features of both u and v are larger than the observations to simulate a large-(p + q)-small-n task. The generating process is as follows. We first generate u and v with
most feature being zero. After that, the latent variable z is constructed from Gaussian distribution N(0, In × n).
Then we create the data X from x i ∼ N (z i u, ∑ x ) and data yi ∼ N (z i v, ∑ y ), where (∑x)jk = exp(−|uj − uk|) and
(∑y)jk = exp(−|vj − vk|). The first three sets have 250 features for u and 600 ones for v, but they have different
correlation coefficients. There are 500 features and 900 features in u and v respectively for the last data set. We
show the true signal of every data set in Fig. 2 (top row).
Real Neuroimaging Genetics Dataset. Data used in the preparation of this article were obtained from the ADNI
database (adni.loni.usc.edu). The ADNI was launched in 2003 as a public-private partnership by the National
Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food
and Drug Administration (FDA) etc, led by Principal Investigator Michael W. Weiner, MD. The primary goal of
ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET),
other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD). For up-to-date information,
see www.adni-info.org. The study protocols were approved by the Institutional Review Boards of all participating
centers (Northwestern Polytechnical University, Indiana University and ADNI (A complete list of ADNI sites
is available at http://www.adni-info.org/)) and written informed consent was obtained from all participants or
authorized representatives. All the analyses were performed on the de-identified ADNI data, and were determined by Indiana University Human Subjects Office as IU IRB Review Not Required.
The real neuroimaging genetics dataset were collected from 743 participants, and the details was presented
in Table 2. There were 163 candidate SNP biomarkers from the AD-risk genes, e.g., APOE, in the genotyping
data. The structural MRI scans were processed with voxel-based morphometry (VBM) in SPM851,52. Briefly,
scans were aligned to a T1-weighted template image, segmented into gray matter (GM), white matter (WM) and
Scientific Reports | 7: 14052 | DOI:10.1038/s41598-017-13930-y
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u

v

Data1

Data2

Data3

Data4

Data1

Data2

Data3

Data4

L1-SCCA

1.00 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.74 ± 0.10

1.00 ± 0.00

1.00 ± 0.00

L1-S2CCA

1.00 ± 0.00

0.38 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.75 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

0.75 ± 0.00

L1-NSCCA

0.80 ± 0.45

0.30 ± 0.41

0.80 ± 0.45

0.40 ± 0.55

1.00 ± 0.00

0.65 ± 0.15

1.00 ± 0.00

0.80 ± 0.27

 γ -norm

1.00 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.76 ± 0.04

1.00 ± 0.00

1.00 ± 0.00

Geman

1.00 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.74 ± 0.01

1.00 ± 0.00

1.00 ± 0.00

SCAD

1.00 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.74 ± 0.02

1.00 ± 0.00

1.00 ± 0.00

Laplace

1.00 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.75 ± 0.02

1.00 ± 0.00

1.00 ± 0.00

MCP

1.00 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.76 ± 0.04

1.00 ± 0.00

1.00 ± 0.00

ETP

1.00 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.76 ± 0.04

1.00 ± 0.00

1.00 ± 0.00

Log

1.00 ± 0.00

0.75 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

1.00 ± 0.00

0.75 ± 0.02

1.00 ± 0.00

1.00 ± 0.00

Table 4. Performance comparison on synthetic data sets. The AUC (area under the curve) values (mean ± std)
of estimated canonical loadings u and v.
Training

Testing

data1

data2

data3

data4

data1

data2

data3

data4

L1-SCCA

0.65 ± 0.03

0.83 ± 0.03

0.65 ± 0.05

0.66 ± 0.04

0.59 ± 0.14

0.82 ± 0.05

0.59 ± 0.25

0.62 ± 0.08

L1-S2CCA

0.51 ± 0.25

0.67 ± 0.30

0.63 ± 0.28

0.32 ± 0.15

0.55 ± 0.23

0.68 ± 0.28

0.53 ± 0.29

0.24 ± 0.20

L1-NSCCA

0.62 ± 0.04

0.80 ± 0.01

0.75 ± 0.01

0.65 ± 0.02

0.61 ± 0.17

0.80 ± 0.04

0.73 ± 0.13

0.65 ± 0.10

 γ -norm

0.62 ± 0.04

0.83 ± 0.01

0.75 ± 0.01

0.65 ± 0.02

0.61 ± 0.17

0.84 ± 0.02

0.73 ± 0.13

0.66 ± 0.10
0.66 ± 0.10

Geman

0.62 ± 0.04

0.83 ± 0.01

0.75 ± 0.01

0.65 ± 0.02

0.62 ± 0.17

0.83 ± 0.02

0.72 ± 0.13

SCAD

0.62 ± 0.04

0.83 ± 0.01

0.75 ± 0.01

0.65 ± 0.03

0.61 ± 0.17

0.84 ± 0.02

0.73 ± 0.13

0.66 ± 0.10

Laplace

0.62 ± 0.04

0.83 ± 0.01

0.75 ± 0.01

0.65 ± 0.02

0.61 ± 0.17

0.83 ± 0.02

0.73 ± 0.13

0.66 ± 0.10
0.66 ± 0.10

MCP

0.62 ± 0.04

0.83 ± 0.01

0.75 ± 0.01

0.65 ± 0.02

0.61 ± 0.17

0.84 ± 0.02

0.73 ± 0.13

ETP

0.62 ± 0.04

0.83 ± 0.01

0.75 ± 0.01

0.65 ± 0.02

0.61 ± 0.17

0.84 ± 0.02

0.73 ± 0.13

0.66 ± 0.10

Log

0.66 ± 0.03

0.83 ± 0.01

0.76 ± 0.01

0.68 ± 0.03

0.62 ± 0.14

0.83 ± 0.03

0.73 ± 0.12

0.67 ± 0.08

Table 5. Training and testing correlation coefficients (mean ± std) of 5-fold cross-validation synthetic data sets.
The best values are shown in boldface.
cerebrospinal fluid (CSF) maps, normalized to MNI space, and smoothed with an 8mm FWHM kernel. We subsampled the whole brain and generated 465 voxels spanning the whole brain ROIs. The regression technique was
employed to remove the effects of the baseline age, gender, education, and handedness for these VBM measures.
The aim of this study is to evaluate the correlation between the SNPs and the VBM measures, and further identify
which SNPs and ROIs are associated.

Experimental Setup. Benchmarks. In this paper, we are mainly interested in whether these non-convex
SCCA methods could enhance the performance of 1-SCCA method based on our motivation. It is reasonable to
employ the 1-norm based methods in comparison. Therefore, the structure-aware SCCA methods such as28,29,32,34
are not contained here as benchmark. Based on different mathematical techniques, there are three different 1
-SCCA algorithms. They are the singular value decomposition based method25, the primal-dual based method29
and the LQA based method32. Though the latter two are proposed for capturing group or network structure, they
can be easily reformulated to the 1-norm constrained methods, such as setting the parameters associated with the
structure penalty to zero29. Therefore, to make the comparison fair and convincing, we choose all of them as
benchmarks. With a slight abuse of notation, we use the penalty name to refer a non-convex SCCA method, e.g.
ETP for ETP based SCCA method. For the 1-norm based methods, we call them L1-SCCA25, L1-S2CCA32, and
L1-NSCCA29.
Parameter Tuning. There are four parameters λi(i = 1, 2) and αi(i = 1, 2) associated with the non-convex SCCA
methods, and one pivotal parameter γ. According to their equations, these non-convex penalties can approximate
the 0-norm by providing an appropriate γ. In this situation, the λi and αi play a very weak role because theoretically the 0-norm penalized problem does not rely on the parameters. Based on this consideration, we here only
tune the γ other than tuning λi and αi by a grid search strategy. This reduces the time consumption dramatically
but does not affect the performance significantly. Further, we observe that two γ's perform similarly if they are not
significantly different. Thus the tuning range of γ is not continuous. Besides, we set γ = 3.7 for SCAD penalty
since38 suggested that this is a very reasonable choice. The details of tuning range for each penalty are contained
in Table 3. For λi and αi, we simply set them to 1 in this study.
Termination Criterion. We use max i|uit +1 − uit | ≤ ε and max j|v jt +1 − v jt| ≤ ε as the termination condition for
Algorithm 1, where ε is the user defined error bound. In this study, we set ε = 10−5 according to experiments. All
Scientific Reports | 7: 14052 | DOI:10.1038/s41598-017-13930-y
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Figure 3. Canonical loadings estimated on real imaging genetics data. Each row corresponds to a SCCA
method: (1) L1-SCCA, (2) L1-NSCCA, (3) L1-S2CCA, (4)  γ -norm and so forth. For each method, the
estimated u is shown on the left panel, and v is on the right one. In each individual heat map, the x-axis indicates
the indices of elements in u or v (i.e., SNPs or ROIs); the y-axis indicates the indices of the cross-validation folds.

Figure 4. Mapping averaged canonical weight v's estimated by every SCCA method onto the brain. The left
panel and right panel show five methods respectively, where each row corresponds to a SCCA method. The
L1-SCCA identifies the most signals, followed by the L1-NSCCA and L1-S2CCA. All the proposed methods
identify a clean signal that helps further investigation.

methods use the same setup, i.e., the same partition of the five-fold cross-validation, running on the same
platform.

Results on Synthetic Data.

Figure 2 shows the heat maps of canonical loadings estimated from all SCCA
methods, where each row corresponds to an experimental method. We clearly observe that the non-convex SCCA
methods and L1-SCCA correctly identify the identical signal positions to the ground truth across four data sets.
Besides true signals, L1-SCCA introduces several undesired signals which makes it be inferior to our methods. As
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L1-SCCA

L1-S2CCA

L1-NSCCA

 γ -norm

Geman

SCAD

Laplace

MCP

ETP

Log

Training

0.27 ± 0.01

0.29 ± 0.02

0.27 ± 0.01

0.28 ± 0.02

0.27 ± 0.02

0.29 ± 0.02

0.27 ± 0.02

0.28 ± 0.02

0.28 ± 0.02

0.33 ± 0.03

Testing

0.18 ± 0.04

0.25 ± 0.10

0.22 ± 0.07

0.26 ± 0.09

0.26 ± 0.10

0.27 ± 0.09

0.26 ± 0.10

0.26 ± 0.09

0.26 ± 0.09

0.27 ± 0.11

Training-Testing Gap

0.09

0.04

0.05

0.02

0.01

0.02

0.01

0.02

0.02

0.06

Table 6. Performance comparison on real data set. Training and testing correlation coefficients (mean ± std) of
5-fold cross-validation are shown. The best value is shown in boldface.

a contrast, L1-NSCCA finds out an incomplete proportion of the ground truth, and L1-S2CCA performs unstably
as it fails on some folds. Moreover, we also prioritize these methods using the AUC (area under ROC) criterion in
Table 4, where a higher value indicates a better performance. The results exhibit that the non-convex SCCA methods have the highest score at almost every case. L1-SCCA scores similarly to the proposed methods, but later we
can see it pays the price at a reduced prediction ability. Table 5 presents the estimated correlation coefficients on
both training and testing data, where the best values are shown in boldface. The proposed SCCA methods alternatively gain the best value, and the Log method wins out for the most times. This demonstrates that the
non-convex methods outperform 1-norm based SCCA methods in terms of the prediction power. In summary,
the proposed methods identify accurate and sparse canonical loading patterns and obtain high correlation coefficients simultaneously, while those 1-norm based SCCA methods cannot.

Results on Real Neuroimaging Genetics Data. In this real data study, the genotyping data is denoted by
X, and the imaging data is denoted by Y. The u is a vector of weights of all SNPs, and v is a vector of weights of all
imaging markers.The canonical correlation coefficients are defined as Pearson correlation coefficient between Xu
and Yv, i.e., (Xu)Τ Yv/( Xu Yv ).
Figure 3 presents the heat maps regrading the canonical loadings generated from the training set. In this figure, each row shows two weights of a SCCA method, where a larger weight stands for a more importance. The
weight associated with the SNPs is on the left panel, and that associated with the voxels is on the right. The proposed non-convex SCCA methods obtain very clean and sparse weights for both u and v. The largest signal on the
genetic side is the APOE e4 SNP rs429358, which has been previously reported to be related to AD53. On the right
panel, the largest signal for all SCCA methods comes from the hippocampus region. This is one of the most notable biomarkers as an indicator of AD, since atrophy of hippocampus has been shown to be related to brain atrophy
and neuron loss measured with MRI in AD cohort53. In addition, the L1-S2CCA and SCAD methods identify a
weak signal from the parahippocampal gyrus, which is previously reported as an early biomarker of AD54. On
some folds, the Log method also finds out the lingual region, parahippocampal gyrus, vermis region. Interestingly,
all the three regions have shown to be correlated to AD, and could be further considered as an indicating biomarker that can be observed prior to a dementia diagnosis. For example, Sjöbeck and Englund reported that
molecular layer gliosis and atrophy in the vermis are clearly severer in AD patients than in the health controls55.
This is meaningful since the non-convex SCCA methods identify the correct clue for further investigation. On
this account, both L1-SCCA and L1-NSCCA are not good choices since they identify too many signals, which
may misguide subsequent investigation. The figure shows that L1-S2CCA could be an alternative choice for sparse
imaging genetics analysis, but it performs unstably across the five folds. And, the non-convex methods is more
consistent and stable than those 1-SCCA methods. To show the results more clearly, we map the canonical
weights (averaged across 5 folds) regarding the imaging measurements from each SCCA method onto the brain
in Fig. 4. The figure confirms that the L1-SCCA and L1-NSCCA find out many signals that are not sparse. The
L1-S2CCA identifies fewer signals than both L1-SCCA and L1-NSCCA, but more than all these non-convex
SCCA methods. All the non-convex SCCA only highlights a small region of the whole brain. This again reveals
that the proposed methods have better canonical weights which reduces the effort of further investigation.
Besides, we include both training and testing correlation coefficients in Table 6, where their mean and standard deviation are shown. The training results of all methods are similar, with the Log method gains the highest
value of 0.33 ± 0.03. As for the testing results, which is our primary interest, all the non-convex SCCA methods
obtain better values than these 1-SCCA methods. Besides, the difference between the training and testing performance of the proposed methods is much smaller than that of three 1-SCCA methods. This means that the
non-convex methods have better generalization performance as they are less likely to fall into overfitting issue.
The result of this real imaging genetics data reveals that the proposed SCCA methods can extract more accurate
and sparser canonical weights for both genetic and imaging biomarkers, and obtain higher correlation coefficients
than those 1-SCCA methods.

Conclusion

We have proposed a unified non-convex SCCA model and an efficient optimization algorithm using a family of
non-convex penalty functions. These penalties are concave and piecewise continuous, and thus piecewise differentiable. We approximate these non-convex penalties by an 2 function via the local quadratic approximation
(LQA)38. Therefore, the proposed algorithm is effective and runs fast.
We compare the non-convex methods with three state-of-the-art 1-SCCA methods using both simulation
data and real imaging genetics data. The simulation data have different ground truth structures. The results on the
simulation data show that the non-convex SCCA methods identify cleaner and better canonical loadings than the
three 1-SCCA methods, i.e. L1-SCCA25, L1-S2CCA32, and L1-NSCCA29. These non-convex methods also recover
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higher correlation coefficients than 1-SCCA methods, demonstrating that 1-SCCA methods have suboptimal
prediction capability as they may over penalize large coefficients. The results on the real data show that the proposed methods discover a pair of meaningful genetic and brain imaging biomarkers, while the 1-SCCA methods
return too many irrelevant signals. The correlation coefficients show that the non-convex SCCA methods hold
better testing values. This verifies our motivation that the non-convex penalty can improve the prediction ability,
and thus has better generalization capability. Obviously, the parameter γ plays a key role in these non-convex
penalties. In the future work, we will investigate how to choose a reasonable γ; and explore how to incorporate
structure information into the model as structure information extraction is an important task for brain imaging
genetics as well as biology studies.

References

1. Hibar, D. P., Kohannim, O., Stein, J. L., Chiang, M.-C. & Thompson, P. M. Multilocus genetic analysis of brain images. Frontiers in
Genetics 2, 73 (2011).
2. Hariri, A. R., Drabant, E. M. & Weinberger, D. R. Imaging genetics: perspectives from studies of genetically driven variation in
serotonin function and corticolimbic affective processing. Biological psychiatry 59, 888–897 (2006).
3. Viding, E., Williamson, D. E. & Hariri, A. R. Developmental imaging genetics: challenges and promises for translational research.
Development and Psychopathology 18, 877–892 (2006).
4. Mattay, V. S., Goldberg, T. E., Sambataro, F. & Weinberger, D. R. Neurobiology of cognitive aging: insights from imaging genetics.
Biological psychology 79, 9–22 (2008).
5. Bigos, K. L. & Weinberger, D. R. Imaging genetics - days of future past. Neuroimage 53, 804–809 (2010).
6. Scharinger, C., Rabl, U., Sitte, H. H. & Pezawas, L. Imaging genetics of mood disorders. Neuroimage 53, 810–821 (2010).
7. Potkin, S. G. et al. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological
considerations. Cognitive neuropsychiatry 14, 391–418 (2009).
8. Kim, S. et al. Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel. PLoS One 8, e70269
(2013).
9. Shen, L. et al. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and
AD: A study of the ADNI cohort. Neuroimage 53, 1051–63 (2010).
10. Winkler, A. M. et al. Cortical thickness or grey matter volume? the importance of selecting the phenotype for imaging genetics
studies. Neuroimage 53, 1135–1146 (2010).
11. Meda, S. A. et al. A large scale multivariate parallel ica method reveals novel imaging–genetic relationships for alzheimer’s disease
in the adni cohort. Neuroimage 60, 1608–1621 (2012).
12. Nho, K. et al. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume
in mild cognitive impairment. Molecular psychiatry 18, 781 (2013).
13. Shen, L. et al. Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain imaging and
behavior 8, 183–207 (2014).
14. Saykin, A. J. et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimer’s
& Dementia 11, 792–814 (2015).
15. Wang, H. et al. Identifying quantitative trait loci via group-sparse multitask regression and feature selection: an imaging genetics
study of the ADNI cohort. Bioinformatics 28, 229–237 (2012).
16. Vounou, M., Nichols, T. E. & Montana, G. Discovering genetic associations with high-dimensional neuroimaging phenotypes: A
sparse reduced-rank regression approach. NeuroImage 53, 1147–59 (2010).
17. Vounou, M. et al. Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in
alzheimer’s disease. Neuroimage 60, 700–716 (2012).
18. Zhu, X., Suk, H.-I., Huang, H. & Shen, D. Structured sparse low-rank regression model for brain-wide and genome-wide
associations. In International Conference on Medical Image Computing and Computer-Assisted Intervention, 344–352 (Springer,
2016).
19. Liu, J. et al. Combining fmri and snp data to investigate connections between brain function and genetics using parallel ica. Human
brain mapping 30, 241–255 (2009).
20. Geladi, P. & Kowalski, B. R. Partial least-squares regression: a tutorial. Analytica chimica acta 185, 1–17 (1986).
21. Grellmann, C. et al. Comparison of variants of canonical correlation analysis and partial least squares for combined analysis of mri
and genetic data. NeuroImage 107, 289–310 (2015).
22. Hardoon, D., Szedmak, S. & Shawe-Taylor, J. Canonical correlation analysis: An overview with application to learning methods.
Neural Computation 16, 2639–2664 (2004).
23. Hardoon, D. R. & Shawe-Taylor, J. Sparse canonical correlation analysis. Machine Learning 83, 331–353 (2011).
24. Hotelling, H. Relations between two sets of variates. Biometrika 28, 321–377 (1936).
25. Witten, D. M., Tibshirani, R. & Hastie, T. A penalized matrix decomposition, with applications to sparse principal components and
canonical correlation analysis. Biostatistics 10, 515–34 (2009).
26. Witten, D. M. & Tibshirani, R. J. Extensions of sparse canonical correlation analysis with applications to genomic data. Statistical
applications in genetics and molecular biology 8, 1–27 (2009).
27. Parkhomenko, E., Tritchler, D. & Beyene, J. Sparse canonical correlation analysis with application to genomic data integration.
Statistical Applications in Genetics and Molecular Biology 8, 1–34 (2009).
28. Chen, X., Liu, H. & Carbonell, J. G. Structured sparse canonical correlation analysis. In International Conference on Artificial
Intelligence and Statistics, 199–207 (2012).
29. Chen, X. & Liu, H. An efficient optimization algorithm for structured sparse cca, with applications to EQTL mapping. Statistics in
Biosciences 4, 3–26 (2012).
30. Chen, J. & Bushman, F. D. et al. Structure-constrained sparse canonical correlation analysis with an application to microbiome data
analysis. Biostatistics 14, 244–258 (2013).
31. Lin, D., Calhoun, V. D. & Wang, Y.-P. Correspondence between fMRI and SNP data by group sparse canonical correlation analysis.
Medical image analysis 18, 891–902 (2014).
32. Du, L. et al. A novel structure-aware sparse learning algorithm for brain imaging genetics. In International Conference on Medical
Image Computing and Computer Assisted Intervention, 329–336 (2014).
33. Yan, J. et al. Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm. Bioinformatics
30, i564–i571 (2014).
34. Du, L. et al. Structured sparse canonical correlation analysis for brain imaging genetics: An improved graphnet method.
Bioinformatics 32, 1544–1551 (2016).
35. Du, L. et al. Sparse canonical correlation analysis via truncated l1-norm-norm with application to brain imaging genetics. In IEEE
International Conference on Bioinformatics and Biomedicine, 707–711 (IEEE, 2016).

Scientific Reports | 7: 14052 | DOI:10.1038/s41598-017-13930-y

10

www.nature.com/scientificreports/
36. Du, L. et al. Identifying associations between brain imaging phenotypes and genetic factors via a novel structured scca approach. In
International Conference on Information Processing in Medical Imaging, 543–555 (Springer, 2017).
37. Meinshausen, N. & Bühlmann, P. High-dimensional graphs and variable selection with the lasso. The annals of statistics 1436–1462
(2006).
38. Fan, J. & Li, R. Variable selection via nonconcave penalized likelihood and its oracle properties. Journal of the American Statistical
Association 96, 1348–1360 (2001).
39. Zou, H. The adaptive lasso and its oracle properties. Journal of the American Statistical Association 101, 1418–1429 (2006).
40. Shen, X., Pan, W. & Zhu, Y. Likelihood-based selection and sharp parameter estimation. Journal of the American Statistical
Association 107, 223–232 (2012).
41. Fung, G. & Mangasarian, O. Equivalence of minimal l0-and lp-norm solutions of linear equalities, inequalities and linear programs
for sufficiently small p. Journal of optimization theory and applications 151, 1–10 (2011).
42. Frank, L. E. & Friedman, J. H. A statistical view of some chemometrics regression tools. Technometrics 35, 109–135 (1993).
43. Geman, D. & Yang, C. Nonlinear image recovery with half-quadratic regularization. IEEE Transactions on Image Processing 4,
932–946 (1995).
44. Trzasko, J. & Manduca, A. Highly undersampled magnetic resonance image reconstruction via homotopic l1-minimization. IEEE
Transactions on Medical imaging 28, 106–121 (2009).
45. Zhang, C. Nearly unbiased variable selection under minimax concave penalty. Annals of Statistics 38, 894–942 (2010).
46. Gao, C., Wang, N., Yu, Q. & Zhang, Z. A feasible nonconvex relaxation approach to feature selection. In AAAI, 356–361 (2011).
47. Friedman, J. H. Fast sparse regression and classification. International Journal of Forecasting 28, 722–738 (2012).
48. Gorski, J., Pfeuffer, F. & Klamroth, K. Biconvex sets and optimization with biconvex functions: a survey and extensions. Mathematical
Methods of Operations Research 66, 373–407 (2007).
49. Lu, C., Tang, J., Yan, S. & Lin, Z. Generalized nonconvex nonsmooth low-rank minimization. In IEEE Conference on Computer
Vision and Pattern Recognition, 4130–4137 (2014).
50. Hunter, D. R. & Li, R. Variable selection using mm algorithms. Annals of statistics 33, 1617 (2005).
51. Ashburner, J. & Friston, K. J. Voxel-based morphometry–the methods. Neuroimage 11, 805–21 (2000).
52. Risacher, S. L. & Saykin, A. J. et al. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Current
Alzheimer Research 6, 347–61 (2009).
53. Hampel, H. et al. Core candidate neurochemical and imaging biomarkers of alzheimer’s disease. Alzheimer’s & Dementia 4, 38–48
(2008).
54. Echavarri, C. et al. Atrophy in the parahippocampal gyrus as an early biomarker of alzheimer’s disease. Brain Structure and Function
215, 265–271 (2011).
55. Sjöbeck, M. & Englund, E. Alzheimer’s disease and the cerebellum: a morphologic study on neuronal and glial changes. Dementia
and geriatric cognitive disorders 12, 211–218 (2001).

Acknowledgements

Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award
number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of
Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie,
Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen;
Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and
Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE
Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson
Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics,
LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal
Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of
Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are
facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is
the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s
Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the
Laboratory for Neuro Imaging at the University of Southern California. L. Du was supported by the National
Natural Science Foundation of China (61602384); the Natural Science Basic Research Plan in Shaanxi Province
of China (2017JQ6001); the China Postdoctoral Science Foundation (2017M613202); and the Fundamental
Research Funds for the Central Universities (3102016OQD0065) at Northwestern Polytechnical University. This
work was also supported by the National Institutes of Health R01 EB022574, R01 LM011360, U01 AG024904,
P30 AG10133, R01 AG19771, UL1 TR001108, R01 AG 042437, R01 AG046171, R01 AG040770; the Department
of Defense W81XWH-14-2-0151, W81XWH-13-1-0259, W81XWH-12-2-0012; the National Collegiate Athletic
Association 14132004 at Indiana University.

Author Contributions

L.D., L.G. and L.S. conceived and designed the research. L.D., K.L. and J.H. carried out the study analysis. X.Y., J.Y,
S.L.R. and A.J.S. collected the data from ADNI database. L.D., K.L., L.S. and A.J.S. analyzed the results and wrote
the paper. Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging
Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the
design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this
report.

Additional Information

Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.

Scientific Reports | 7: 14052 | DOI:10.1038/s41598-017-13930-y

11

www.nature.com/scientificreports/
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2017

Scientific Reports | 7: 14052 | DOI:10.1038/s41598-017-13930-y

12

www.nature.com/scientificreports/

Consortia
Alzheimer’s Disease Neuroimaging Initiative
Michael W. Weiner3, Paul Aisen4, Ronald Petersen5, Clifford R. Jack5, William Jagust6, John Q.
Trojanowki7, Arthur W. Toga4, Laurel Beckett8, Robert C. Green9, John Morris10, Leslie M.
Shaw7, Zaven Khachaturian11, Greg Sorensen12, Maria Carrillo13, Lew Kuller14, Marc Raichle10,
Steven Paul15, Peter Davies16, Howard Fillit17, Franz Hefti18, David Holtzman10, M. Marcel
Mesulam19, William Potter20, Peter Snyder21, Adam Schwartz22, Tom Montine23, Ronald G.
Thomas24, Michael Donohue24, Sarah Walter24, Devon Gessert24, Tamie Sather24, Gus
Jiminez24, Archana B. Balasubramanian24, Jennifer Mason24, Iris Sim24, Danielle Harvey8,
Matthew Bernstein5, Nick Fox25, Paul Thompson26, Norbert Schuff3, Charles DeCArli8, Bret
Borowski5, Jeff Gunter5, Matt Senjem5, Prashanthi Vemuri5, David Jones5, Kejal Kantarci5,
Chad Ward5, Robert A. Koeppe27, Norm Foster28, Eric M. Reiman29, Kewei Chen29, Chet
Mathis14, Susan Landau6, Nigel J. Cairns10, Erin Franklin10, Lisa Taylor-Reinwald10, Virginia
Lee7, Magdalena Korecka7, Michal Figurski7, Karen Crawford4, Scott Neu4, Tatiana M.
Foroud2, Steven Potkin30, Kelley Faber2, Sungeun Kim2, Kwangsik Nho2, Leon Thal24, Neil
Buckholtz31, Marilyn Albert32, Richard Frank33, John Hsiao31, Jeffrey Kaye34, Joseph Quinn34,
Lisa Silbert34, Betty Lind34, Raina Carter34, Sara Dolen34, Lon S. Schneider4, Sonia Pawluczyk4,
Mauricio Beccera4, Liberty Teodoro4, Bryan M. Spann4, James Brewer24, Helen Vanderswag24,
Adam Fleisher24, Judith L. Heidebrink27, Joanne L. Lord27, Sara S. Mason5, Colleen S. Albers5,
David Knopman5, Kris Johnson5, Rachelle S. Doody35, Javier Villanueva-Meyer35, Valory
Pavlik35, Victoria Shibley35, Munir Chowdhury35, Susan Rountree35, Mimi Dang35, Yaakov
Stern36, Lawrence S. Honig36, Karen L. Bell36, Beau Ances10, Maria Carroll10, Mary L. Creech10,
Erin Franklin10, Mark A. Mintun10, Stacy Schneider10, Angela Oliver10, Daniel Marson37, David
Geldmacher37, Marissa Natelson Love37, Randall Griffith37, David Clark37, John Brockington37,
Erik Roberson37, Hillel Grossman38, Effie Mitsis38, Raj C. Shah39, Leyla deToledo-Morrell39,
Ranjan Duara40, Maria T. Greig-Custo40, Warren Barker40, Chiadi Onyike32, Daniel
D’Agostino32, Stephanie Kielb32, Martin Sadowski41, Mohammed O. Sheikh41, Anaztasia
Ulysse41, Mrunalini Gaikwad41, P. Murali Doraiswamy42, Jeffrey R. Petrella42, Salvador BorgesNeto42, Terence Z. Wong42, Edward Coleman42, Steven E. Arnold7, Jason H. Karlawish7, David
A. Wolk7, Christopher M. Clark7, Charles D. Smith43, Greg Jicha43, Peter Hardy43, Partha
Sinha43, Elizabeth Oates43, Gary Conrad43, Oscar L. Lopez14, Mary Ann Oakley14, Donna M.
Simpson14, Anton P. Porsteinsson44, Bonnie S. Goldstein44, Kim Martin44, Kelly M. Makino44,
M. Saleem Ismail44, Connie Brand44, Adrian Preda30, Dana Nguyen30, Kyle Womack45, Dana
Mathews45, Mary Quiceno45, Allan I. Levey46, James J. Lah46, Janet S. Cellar46, Jeffrey M.
Burns47, Russell H. Swerdlow47, William M. Brooks47, Liana Apostolova26, Kathleen Tingus26,
Ellen Woo26, Daniel H. S. Silverman26, Po H. Lu26, George Bartzokis26, Neill R Graff-Radford48,
Francine Parfitt48, Kim Poki-Walker48, Martin R. Farlow2, Ann Marie Hake2, Brandy R.
Matthews2, Jared R. Brosch2, Scott Herring2, Christopher H. van Dyck49, Richard E. Carson49,
Martha G. MacAvoy49, Pradeep Varma49, Howard Chertkow50, Howard Bergman50, Chris
Hosein50, Sandra Black51, Bojana Stefanovic51, Curtis Caldwell51, Ging-Yuek Robin Hsiung52,
Benita Mudge52, Vesna Sossi52, Howard Feldman52, Michele Assaly52, Elizabeth Finger53,
Stephen Pasternack53, Irina Rachisky53, John Rogers53, Dick Trost53, Andrew Kertesz53,
Charles Bernick54, Donna Munic54, Emily Rogalski19, Kristine Lipowski19, Sandra Weintraub19,
Borna Bonakdarpour19, Diana Kerwin19, Chuang-Kuo Wu19, Nancy Johnson19, Carl
Sadowsky55, Teresa Villena55, Raymond Scott Turner56, Kathleen Johnson56, Brigid
Reynolds56, Reisa A. Sperling9, Keith A. Johnson9, Gad Marshall9, Jerome Yesavage57, Joy L.
Taylor57, Barton Lane57, Allyson Rosen57, Jared Tinklenberg57, Marwan N. Sabbagh58,
Christine M. Belden58, Sandra A. Jacobson58, Sherye A. Sirrel58, Neil Kowall59, Ronald
Killiany59, Andrew E. Budson59, Alexander Norbash59, Patricia Lynn Johnson59, Thomas O.
Obisesan60, Saba Wolday60, Joanne Allard60, Alan Lerner61, Paula Ogrocki61, Curtis Tatsuoka61,
Parianne Fatica61, Evan Fletcher8, Pauline Maillard8, John Olichney8, Charles DeCarli8, Owen
Carmichael8, Smita Kittur62, Michael Borrie63, T.-Y. Lee63, Rob Bartha63, Sterling Johnson64,
Sanjay Asthana64, Cynthia M. Carlsson64, Pierre Tariot29, Anna Burke29, Ann Marie Milliken29,
Nadira Trncic29, Adam Fleisher29, Stephanie Reeder29, Vernice Bates65, Horacio Capote65,
Michelle Rainka65, Douglas W. Scharre66, Maria Kataki66, Brendan Kelly66, Earl A.
Zimmerman67, Dzintra Celmins67, Alice D. Brown67, Godfrey D. Pearlson68, Karen Blank68,
Karen Anderson68, Laura A. Flashman69, Marc Seltzer69, Mary L. Hynes69, Robert B. Santulli69,
Scientific Reports | 7: 14052 | DOI:10.1038/s41598-017-13930-y

13

www.nature.com/scientificreports/
Kaycee M. Sink70, Leslie Gordineer70, Jeff D. Williamson70, Pradeep Garg70, Franklin Watkins70,
Brian R. Ott71, Geoffrey Tremont71, Lori A. Daiello71, Stephen Salloway72, Paul Malloy72,
Stephen Correia72, Howard J. Rosen3, Bruce L. Miller3, David Perry3, Jacobo Mintzer73,
Kenneth Spicer73, David Bachman73, Nunzio Pomara74, Raymundo Hernando74, Antero
Sarrael74, Susan K. Schultz75, Karen Ekstam Smith75, Hristina Koleva75, Ki Won Nam75,
Hyungsub Shim75, Norman Relkin15, Gloria Chaing15, Michael Lin15, Lisa Ravdin15, Amanda
Smith76, Balebail Ashok Raj76 & Kristin Fargher76
3
University of California, San Francisco, USA. 4University of Southern California, Los Angeles, USA. 5Mayo Clinic,
Rochester, Minnesota, USA. 6University of California, Berkeley, Berkeley, USA. 7University of Pennsylvania,
Philadelphia, USA. 8University of California, Davis, Davis, USA. 9Brigham and Women’s Hospital/Harvard Medical
School, Boston, USA. 10Washington University St. Louis, St. Louis, USA. 11Prevent Alzheimer’s Disease, 2020,
Rockville, USA. 12Siemens, Munich, Germany. 13Alzheimer’s Association, Illinois, USA. 14University of Pittsburgh,
Pennsylvania, USA. 15Cornell University, New York, USA. 16Albert Einstein College of Medicine of Yeshiva University,
New York, USA. 17AD Drug Discovery Foundation, New York, USA. 18Acumen Pharmaceuticals, California, USA.
19
Northwestern University, Illinois, USA. 20National Institute of Mental Health, Maryland, USA. 21Brown University,
Rhode Island, USA. 22Eli Lilly, Indiana, USA. 23University of Washington, Washington, USA. 24University of California,
San Diego, California, USA. 25University of London, London, UK. 26University of California, Los Angeles, California,
USA. 27University of Michigan, Michigan, USA. 28University of Utah, Utah, USA. 29Banner Alzheimer’s Institute,
Arizona, USA. 30University of California, Irvine, California, USA. 31National Institute on Aging, Maryland, USA. 32Johns
Hopkins University, Maryland, USA. 33Richard Frank Consulting, New Hampshire, USA. 34Oregon Health and Science
University, Oregon, USA. 35Baylor College of Medicine, Texas, USA. 36Columbia University Medical Center, New
York, USA. 37University of Alabama-Birmingham, Alabama, USA. 38Mount Sinai School of Medicine, New York, USA.
39
Rush University Medical Center, Rush University, Illinois, USA. 40Wien Center, Florida, USA. 41New York University,
New York, USA. 42Duke University Medical Center, North Carolina, USA. 43University of Kentucky, Kentucky, USA.
44
University of Rochester Medical Center, New York, USA. 45University of Texas Southwestern Medical School,
Texas, USA. 46Emory University, Georgia, USA. 47University of Kansas, Medical Center, Kansas, USA. 48Mayo Clinic,
Jacksonville, Florida, USA. 49Yale University School of Medicine, Connecticut, USA. 50McGill University, MontrealJewish General Hospital, Quebec, Canada. 51Sunnybrook Health Sciences, Ontario, Canada. 52U.B.C. Clinic for AD
& Related Disorders, British Columbia, Canada. 53Cognitive Neurology-St. Joseph’s, Ontario, Canada. 54Cleveland
Clinic Lou Ruvo Center for Brain Health, Ohio, USA. 55Premiere Research Inst (Palm Beach Neurology), Florida, USA.
56
Georgetown University Medical Center, Washington D.C, USA. 57Stanford University, California, USA. 58Banner Sun
Health Research Institute, Arizona, USA. 59Boston University, Massachusetts, USA. 60Howard University, Washington
D.C, USA. 61Case Western Reserve University, Ohio, USA. 62Neurological Care of CNY, New York, USA. 63Parkwood
Hospital, Pennsylvania, USA. 64University of Wisconsin, Wisconsin, USA. 65Dent Neurologic Institute, New York,
USA. 66Ohio State University, Ohio, USA. 67Albany Medical College, New York, USA. 68Hartford Hospital, Olin
Neuropsychiatry Research Center, Connecticut, USA. 69Dartmouth-Hitchcock Medical Center, New Hampshire, USA.
70
Wake Forest University Health Sciences, North Carolina, USA. 71Rhode Island Hospital, Rhode Island, USA. 72Butler
Hospital, Rhode Island, USA. 73Medical University South Carolina, Carolina, USA. 74Nathan Kline Institute, New York,
USA. 75University of Iowa College of Medicine, Iowa, USA. 76USF Health Byrd Alzheimer’s Institute, University of
South Florida, Florida, USA.

Scientific Reports | 7: 14052 | DOI:10.1038/s41598-017-13930-y

14

